Average Co-Inventor Count = 7.42
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glaxosmithkline LLC (4 from 356 patents)
2. Glaxosmithkline Intellectual Property (no.2) Limited (4 from 95 patents)
3. Glaxosmithkline Intellectual Property Development Limited (2 from 230 patents)
4. Other (1 from 832,880 patents)
11 patents:
1. 11478478 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
2. 10815218 - Benzoimidazole derivatives as PAD4 inhibitors
3. 10583139 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
4. 10407407 - Benzoimidazole derivatives as PAD4 inhibitors
5. 10034881 - 2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
6. 9670221 - Furopyridines as bromodomain inhibitors
7. 9663533 - Thieno[3,2-C]pyridin-4(5H)-ones as BET inhibitors
8. 9637456 - 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
9. 9315487 - Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10. 9029395 - Tetrahydroquinoline derivatives useful as bromodomain inhibitors
11. 8993554 - Tetrahydroquinoline derivatives useful as bromodomain inhibitors